← Back to All US Stocks

MCAGU Stock Analysis 2026 - Mountain Crest Acquisition Corp. V AI Rating

MCAGU OTC Surgical & Medical Instruments & Apparatus DE CIK: 0001859035
Recently Updated • Analysis: Apr 1, 2026 • SEC Data: 2025-12-31
STRONG SELL
95% Conf
Pending
Analysis scheduled

📊 MCAGU Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: $-742.0K
Current Ratio: 0.02x
Debt/Equity: N/A
EPS: $0.00
AI Rating: STRONG SELL with 95% confidence

Is MCAGU a Good Investment? Thesis Analysis

Claude

Mountain Crest Acquisition Corp. V exhibits severe financial distress with negative stockholders' equity of -3.7M, indicating liabilities exceed all assets. The company is cash-depleted with only 11.9K in liquid reserves while burning 742K annually in operating cash flow, creating an unsustainable position with critical liquidity crisis.

Why Buy MCAGU? Key Strengths

Claude
  • -No strengths identified

MCAGU Investment Risks to Consider

Claude
  • ! Negative stockholders equity of -3.7M indicating technical insolvency
  • ! Critical liquidity crisis with current ratio of 0.02x and only 11.9K cash against 3.7M liabilities
  • ! Severe cash burn rate of 742K annually in operating cash flow with minimal revenue generation
  • ! Persistent operating losses of 471.8K with no disclosed revenue base
  • ! ROA of -49.4% demonstrates assets are actively destroying value
  • ! No identifiable revenue stream or operational business activity

Key Metrics to Watch

Claude
  • * Cash balance and runway to complete strategic transaction or bankruptcy
  • * Stockholders equity trajectory and debt restructuring negotiations
  • * Form 4 insider activity for evidence of confidence or exit signals

MCAGU Financial Metrics

Revenue
N/A
Net Income
$-431.2K
EPS (Diluted)
$0.00
Free Cash Flow
$-742.0K
Total Assets
$873.6K
Cash Position
$11.9K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

MCAGU Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -49.4%
FCF Margin N/A

MCAGU vs Healthcare Sector

How Mountain Crest Acquisition Corp. V compares to Healthcare sector averages

Net Margin
MCAGU 0.0%
vs
Sector Avg 12.0%
MCAGU Sector
ROE
MCAGU 0.0%
vs
Sector Avg 15.0%
MCAGU Sector
Current Ratio
MCAGU 0.0x
vs
Sector Avg 2.0x
MCAGU Sector
Debt/Equity
MCAGU 0.0x
vs
Sector Avg 0.6x
MCAGU Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is MCAGU Overvalued or Undervalued?

Based on fundamental analysis, Mountain Crest Acquisition Corp. V has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

MCAGU Balance Sheet & Liquidity

Current Ratio
0.02x
Quick Ratio
0.02x
Debt/Equity
N/A
Debt/Assets
426.1%
Interest Coverage
-336.51x
Long-term Debt
N/A

MCAGU 5-Year Financial Trend & Growth Analysis

MCAGU 5-year financial data:
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Mountain Crest Acquisition Corp. V's revenue has remained relatively flat over the 5-year period, with a 0% decline.

MCAGU Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

MCAGU Capital Allocation

Operating Cash Flow
-$742.0K
Cash generated from operations
Dividends
None
No dividend program

MCAGU SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for Mountain Crest Acquisition Corp. V (CIK: 0001859035)

📋 Recent SEC Filings

Date Form Document Action
Mar 16, 2026 10-K mountaincrest5_10k.htm View →
Jan 2, 2026 4 xslF345X05/ownership.xml View →
Jan 2, 2026 4 xslF345X05/ownership.xml View →
Dec 15, 2025 8-K mountaincrest5_8k.htm View →
Nov 14, 2025 10-Q mountaincrest5_10q.htm View →

Frequently Asked Questions about MCAGU

What is the AI rating for MCAGU?

Mountain Crest Acquisition Corp. V (MCAGU) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are MCAGU's key strengths?

Claude: .

What are the risks of investing in MCAGU?

Claude: Negative stockholders equity of -3.7M indicating technical insolvency. Critical liquidity crisis with current ratio of 0.02x and only 11.9K cash against 3.7M liabilities.

What is MCAGU's revenue and growth?

Mountain Crest Acquisition Corp. V reported revenue of N/A.

Does MCAGU pay dividends?

Mountain Crest Acquisition Corp. V does not currently pay dividends.

Where can I find MCAGU SEC filings?

Official SEC filings for Mountain Crest Acquisition Corp. V (CIK: 0001859035) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is MCAGU's EPS?

Mountain Crest Acquisition Corp. V has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is MCAGU a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Mountain Crest Acquisition Corp. V has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is MCAGU stock overvalued or undervalued?

Valuation metrics for MCAGU: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy MCAGU stock in 2026?

Our dual AI analysis gives Mountain Crest Acquisition Corp. V a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is MCAGU's free cash flow?

Mountain Crest Acquisition Corp. V's operating cash flow is $-742.0K, with capital expenditures of N/A.

How does MCAGU compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.02 (avg: 2).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 1, 2026 | Data as of: 2025-12-31 | Powered by Claude AI